Non-Cholinergic Pharmacotherapy Approaches to the Future Treatment of Alzheimers Disease

Author(s): Ana Castro, Santiago Conde, M. Isabel Rodriguez-Franco, Ana Martinez

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 2 , Issue 1 , 2002

Become EABM
Become Reviewer


Research on the molecular basis of Alzheimers disease has elucidated pathogenic pathways from which a range of rational pharmacological interventions has emerged. The most promising strategies involve approaches to retarding, halting or preventing the formation or accumulation of beta amyloid plaques and neurofibrillary tangles. Other therapeutic approaches include those acting via excitatory amino acid receptors, limiting the oxidative stress and inflammatory response associated with dementia, molecules with nerve growth factor like activity. In the present article these and the other recent advances in the neurobiology and pharmacotherapy of AD will be reviewed.

Keywords: Non-Cholinergic Pharmacotherapy, Alzheimers Disease, neurofibrillary tangles, ampakines, acetylcholinesterase (AChE), Tau Hyperphosphorylation, calmoduline kinase

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2002
Page: [37 - 50]
Pages: 14
DOI: 10.2174/1389557023406610

Article Metrics

PDF: 16